New Clinical Trials for Pancreatic Cancer Are Giving Doctors Hope
Pancreatic cancer has proven one of the most challenging cancers to treat, with low survival rates and limited treatment options. However, a wave of innovative clinical trials is now offering new possibilities for pancreatic cancer patients, including those affected by 9/11-related exposures. Advances in targeted therapies, precision medicine, and immunotherapy are changing the world of pancreatic cancer care. For individuals diagnosed after being exposed in the aftermath of the 9/11 terrorist attacks, these advances bring with them hope for more positive outcomes and better treatment options for individuals diagnosed with pancreatic cancer.
